Rakha EA - Search Results

1

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.

Kurozumi S, Alsaleem M, Monteiro CJ, Bhardwaj K, Joosten SEP, Fujii T, Shirabe K, Green AR, Ellis IO, Rakha EA, Mongan NP, Heery DM, Zwart W, Oesterreich S, Johnston SJ. Kurozumi S, et al. Among authors: rakha ea. Breast Cancer Res. 2020 Aug 11;22(1):85. doi: 10.1186/s13058-020-01324-4. Breast Cancer Res. 2020. PMID: 32782013 Free PMC article.

2

Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.

Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. J Pathol. 2004 Jul;203(3):754-61. doi: 10.1002/path.1573. J Pathol. 2004. PMID: 15221934

3

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Putti TC, et al. Among authors: rakha ea. Mod Pathol. 2005 Jan;18(1):26-35. doi: 10.1038/modpathol.3800255. Mod Pathol. 2005. PMID: 15332092 Free article.

4

Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.

Rakha EA, Pinder SE, Paish CE, Ellis IO. Rakha EA, et al. Br J Cancer. 2004 Oct 18;91(8):1591-6. doi: 10.1038/sj.bjc.6602144. Br J Cancer. 2004. PMID: 15354217 Free PMC article.

5

High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.

Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO. Rakha EA, et al. Int J Cancer. 2005 May 1;114(5):720-9. doi: 10.1002/ijc.20738. Int J Cancer. 2005. PMID: 15609312 Free article.

6

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. Abd El-Rehim DM, et al. Int J Cancer. 2005 Sep 1;116(3):340-50. doi: 10.1002/ijc.21004. Int J Cancer. 2005. PMID: 15818618 Free article.

7

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO. Rakha EA, et al. Histopathology. 2005 Jun;46(6):685-93. doi: 10.1111/j.1365-2559.2005.02156.x. Histopathology. 2005. PMID: 15910600

8

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. Mod Pathol. 2005 Oct;18(10):1295-304. doi: 10.1038/modpathol.3800445. Mod Pathol. 2005. PMID: 15976813 Free article.

9

Three dimensional reconstruction of a human breast carcinoma using routine laboratory equipment and immunohistochemistry.

Kurien T, Boyce RW, Paish EC, Ronan J, Maddison J, Rakha EA, Green AR, Ellis IO. Kurien T, et al. Among authors: rakha ea. J Clin Pathol. 2005 Sep;58(9):968-72. doi: 10.1136/jcp.2004.024794. J Clin Pathol. 2005. PMID: 16126880 Free PMC article.

10

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. J Pathol. 2006 Mar;208(4):495-506. doi: 10.1002/path.1916. J Pathol. 2006. PMID: 16429394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

500 results

Search Page